Platinum corporate sponsors
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.co.uk
Almirall are an International Pharmaceutical company based on innovation and committed to health, based in Barcelona, Spain. Almirall research, develop, produce and market proprietary R&D medicines and those under licence with the aim of improving people’s health and well being. Almirall UK are currently focused on a Dermatology portfolio.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialisation of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. Celgene UK & Ireland is a subsidiary of Celgene Corporation. For more information, please visit www.celgene.co.uk
Immunology Company Information At Janssen, innovation is in our nature – we strive to continually deliver pioneering solutions in immunology through dedicated research and collaboration. • We are proud to have one of the strongest treatment portfolios for some of the most common immune and inflammatory diseases across dermatology, rheumatology and gastroenterology. • Janssen invests in an extensive presence and multiple partnerships across Europe and Middle East and Africa (EMEA) region to support progress in immunology. • We make R&D investments in the field of Immunology of more than €1.5 billion annually
Date of Preparation: April 2018 Job Bag: PHGB/GUS/0418/0002
LEO Pharma is a global pharmaceutical company dedicated to helping people achieve healthy skin. Headquartered in Denmark, with 4,600 employees in 61 countries our products are sold in over 100 countries. Being owned by the LEO Foundation, with no external shareholders, profits are reinvested to benefit patients.
Within dermatology LEO delivers treatments for psoriasis, infected eczema and skin infections. LEO Pharma also delivers treatments for thrombosis (blood clotting). LEO Pharma is also committed to helping healthcare providers deliver quality patient care through innovative redesign of healthcare services in the evolving NHS along with the provision of comprehensive patient support and education.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
To learn more about Lilly, please visit us at www.lilly.co.uk
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what’s right, not what’s easy; and impact the future through passionate global leadership. We market a growing portfolio of approximately 7,500 products around the world, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend.
We market our products in more than 165 countries and territories.
Novartis transform patients’ lives by targeting progressive illnesses in the Specialty Dermatology and Rheumatology fields, where there are high unmet medical needs.
More information at www.novartis.co.uk
T+R Derma, incorporating the Cetraben and Zeroderma brands, offers the most comprehensive choice of emollients for patients with dry skin conditions. Clinically effective, cosmetically acceptable, Cetraben helps provide patients with confidence and freedom from eczema and dry skin. Zeroderma offers similar formulations to leading brands with cost savings of up to 37% without compromising on patient care.
Gold corporate sponsors
Both sensitive and strong, our skin envelops and protects us.
It resists the drying wind and the burning sun; it repairs our wounds. It feels our emotions and the benefits of the sun.
It is our greatest ally, the protector of our body.
At BIODERMA, skin is our passion, our expertise, our model.
It is by observing skin’s biology and analysing what it naturally does best, that we found the inspiration to create dermatological skin cares that restore its natural balance to strengthen it.
THE SKIN ITSELF inspired BIODERMA to find biological solutions to preserve the health and beauty of our skin.
Alliance Pharmaceuticals Ltd together with KELO-COTE© is delighted to support the BDNG. The KELO-COTE© patented range of products includes a gel, a spray and UV gel which are used for the treatment and prevention of keloid and hypertrophic scars. KELO-COTE©’s advanced formula has been clinically proven to help flatten, smooth and reduce the redness associated with scarring. For more information about our company and range of KELO-COTE© products please visit www.kelocote.co.uk, email firstname.lastname@example.org, or call us on 01249 466966
Biofrontera is a biopharmaceutical company specialized in the field of dermatology. Our particular focus lies in the management of non-melanoma skin cancers (NMSC) through both conventional and daylight-mediated photodynamic therapy. These are areas in which we have developed considerable scientific and clinical expertise over a period of many years. Founded in 1997, Biofrontera currently employs around 130 staff worldwide.
Crawford Healthcare is a supplier of dermatology and woundcare products covering a broad range of skin conditions. We are dedicated to developing and providing innovative treatment solutions to care and repair the skin, helping our bodies to maintain our number one natural defence system. Website: www.crawfordhealthcare.co.uk
We are a small specialist pharmaceutical company dedicated to the field of dermatology. Our aim is to provide cost-effective treatments for all prescribers and to assist CCG’s and Health Trusts to maximise their budgets. Our products include Ultrabase emollient and Sebco Ointment. Website: www.dermauk.co.uk
For over 50 years, Dermal have been developing highly effective, cosmetically elegant and clinically proven treatments for application to the skin. It is the performance of the whole formulation that makes the difference.
Dermal’s popular dermatology medicines are further supported by our commitment towards prescribers and patients, including educational items to empower patients in the management of their skin condition.
We remain dedicated to building on Dermal’s history, as a specialist, independent, British pharmaceutical company, promoting successful topical innovation and supporting dermatology for the benefit of future generations. Website: www.dermal.co.uk
Dermatonics is well-known for Dermatonics Once Heel Balm which is widely prescribed as a treatment for Diabetic Foot Callus and in Lymphoedema. We have now launched a unique new concept in Ultraveen Itch Relief Cream which combines Urea and Colloidal Oatmeal. These two widely used ingredients work synergistically to hydrate and protect skin. Trial results are outstanding and we also offer great value compared to the other itch relief products available on the Drug Tariff.
Ultraveen Itch Relief cream stopped itch in 95% of users within 1 day of application and 100% of users said they’d recommend it to a friend
Dating back to 1961, Galderma is now present in over 100 countries, with 35 affiliates and more than 6,000 employees and has an extensive product portfolio of medical solutions to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails. For more information, please visit www.galderma.co.uk
Mölnlycke Health Care
Mölnlycke is world-leading medical solutions company.
Our purpose is to advance performance in healthcare across the world, and we aspire to equip everybody in healthcare with solutions to achieve the best outcomes.